AL Sydbank A/S
25.3.2026 16:10:50 CET | Globenewswire | Press release
Correction of financial calendar 2026
Correction of financial calendar 2026
Company Announcement No 14/2026 | Peberlyk 4 6200 Aabenraa Denmark Tel +45 74 37 37 37 AL Sydbank A/S CVR No DK 12626509, Aabenraa al-sydbank.com |
| 25 March 2026 |
Dear Sirs
Correction of financial calendar 2026
AL Sydbank has adjusted the date for release of the Interim Report for Q1-Q3 2026 which has been changed from 4 November 2026 to 5 November 2026.
In 2026 the Group’s preliminary announcement of financial statements will be released as follows:
- Interim Report – Q1 2026
6 May 2026
- Interim Report – First Half 2026
26 August 2026
- Interim Report – Q1-Q3 2026
5 November 2026
The preliminary announcements of financial statements are expected to be released at 8.00am on the dates listed above.
The preliminary announcements of financial statements will be available at
al-sydbank.dk and al-sydbank.com immediately following their release.
Yours sincerely
AL Sydbank A/S
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Sanoma Corp25.3.2026 17:30:00 CET | Press release
SANOMA CORPORATION: ACQUISITION OF OWN SHARES 25 March 2026
Io Therapeutics, Inc.25.3.2026 17:15:00 CET | Press release
Io Therapeutics, Inc. announces publication in Scientific Reports – Nature, of studies showing synergistic efficacy of its RXR agonist IRX4204 with the standard of care drug lenalidomide against multiple myeloma.
DFDS A/S25.3.2026 17:01:09 CET | Press release
DFDS A/S – SUMMARY OF ANNUAL GENERAL MEETING
DFDS A/S25.3.2026 17:01:09 CET | Pressemeddelelse
DFDS A/S – FORLØB AF ORDINÆR GENERALFORSAMLING
A.P. Møller - Mærsk A/S25.3.2026 16:32:12 CET | Press release
Development of the Annual General Meeting on Wednesday 25 March 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom